Khadija Mansour, Zohra Chadli, Najah Ben Fadhel, Nadia Ben Fredj, Haifa Ben Romdhane, Amel Chaabane, Adnene Toumi, Karim Aouam
DRESS related to first-line antituberculosis drugs (ATD) is a challenging diagnosis. With a long-lasting combined treatment of 4-concomitantly administrated drugs, identification of the culprit drug remains difficult and may expose patients to treatment interruption and affect their outcome. A 42-year-old female, treated with isoniazid, rifampicin, pyrazinamide and ethambutol for multifocal tuberculosis, developed, 40 days later, hyperthermia, facial edema, cervical lymphadenopathy and generalized exanthema...
February 2024: Hospital Pharmacy